Name: 6th Annual MarketsandMarkets Next-Gen Microbiome and Probiotics Conference
Start: 2024-02-08
End: 2024-02-09
Location: Double Tree by Hilton, San Diego - Mission Valley | 7450 Hazard Centre Drive San Diego, CA 92108

WHAT TO EXPECT

Effective Microbiome Therapeutics in Production
Role of human skin microbiome in precision health
The increasing pro bacterial beauty industry
Business collaborations- Regulations and Investments
Microbiome as a science and its clinical applications- skin, gut & women’s health
Regulatory pathways
Prebiotics, Probiotics and Postbiotics
R&D to commercialization- effectively translating research into commercialization
Rightly educating the consumer

Industry & academia

Industry –

Pharmaceuticals
Nutraceuticals
Therapeutics

Designations -

Chief executives , VP’s , Senior Directors , Directors, Global heads , Heads, Leaders, Senior Managers, Program Manager, Manager, Researcher, Analyst, Scientists, Methodologists, Principal Investigators, Principal scientist, Project leader, Clinical research professionals

From the departments-

Microbiome, Microbiome discovery, Department of Biochemistry, Microbiome science, Microbiology, Biological Science, Gut Biology, Human microbiome, Therapeutics, Immunotherapy, Dermatology, Meta Genomics, Diet & health, Dietary supplement, Probiotics

Academia-

Directors, Heads, Professors/Assistant Professors/ Associate Professor, Research Scholars, Scientists from the departments of:

Microbiology, Microbiome therapeutics, Microbiome, Gastroenterology, Neonatology, Functional foods, Nutritionists/dieticians, Gut inflammation, Mucosal immunity, Immunopharmacology Group, Metagenomics, Food Scientist, food/gut microbiome specialist, Quality, Control Microbiologist, Group Manager, Food Protection & Probiotics, Microbiology Laboratory Technician, Microbiome disease, Bioinformatics, Microbiome scientists, Pediatrics, Microbiology Research Sites, Pathologists and Immunologists, Research Scientists

CONFERENCE AGENDA

Registration	08:15 - 08:50
Welcome note from MarketsandMarkets	08:50 - 08:55
Opening Remarks from the Chairperson Julius Goepp, CEO, Evimero	08:55 - 09:00
UNVEILING TOMORROW’S HEALTH WITH NEW MICROBIOME FINDINGS
Keynote Presentation-An Accurate Cost Effective Long Read Solution Using Short Read NGS Platforms for Microbiome Research and Discovery. Ming Lei, President and CEO, Universal Sequencing Technology	09:00 - 09:30
Taxonomy- and Disease Agnostic Approach to Microbiome Therapeutics Julius Goepp, CEO, Evimero	09:30 - 10:00
Development of human primary cell-culture derived mucus to support microbiome research Niki Heinz, Sr. Director of Business Development, , Altis Biosystems	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:30 - 11:15
Oral-Systemic Microbiome Connection and its Modulation Emily Stein, CEO, Primal Health Inc.	11:15 - 11:45
What is in Your Bottle? Dana Buckman, CEO, BioForm Solutions	11:45 - 12:15
Biocalorimetry, the science behind the calScreener™, is revolutionizing the way companies approach the development of probiotics. This technology simplifies the study of complex interactions, conserves valuable time and resources in screening, and can be instrumental in ensuring product safety and efficacy. The calScreener™ has demonstrated high value in media optimization for probiotic production, and providing phenotypic readouts in opaque and complex growth media. Its key benefits include rapid analysis, non-destructive assay, and the ability to run any type of media. It offers direct metabolism measurement from single and multi-species cultures, and activity yield, setting a new standard in the field. Katrin Beilharz, Technical Marketing Specialist, Symcel	12:15 - 12:45
Next-Generation Probiotics Against Enteric Pathogen Infection and Chronic Inflammatory Disease Arun K. Bhunia, Professor of Food Microbiology, Chair, Interdepartmental Food Science Graduate Program, Department of Food Science, Purdue Institute of Inflammation, Immunology and Infectious Disease	12:45 - 13:15
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:15 - 14:15
Revolutionizing wellness – exploring the future of microbiome and probiotics How Lifestyle and Life Stages affect Gut Microbiota and the power of Biotics. Miguel Freitas, Vice President - Scientific Affairs, Danone	14:15 - 14:45
Effect of Back to Health - An Evolutionary Biology Perspective on the Skin Microbiome Larry Weiss, Chief Executive Officer and Founder, Symbiome	14:45 - 15:15
Working with live probiotics – insights in developing effective skincare products from formulator’s perspective Maya Ivanjesku, Chief Scientific Officer, M2B Pharma	15:15 - 15:45
Afternoon Refreshments and Poster Presentations \| One-to-One Networking Meetings	15:45 - 16:30
Synbiotics for Human Health – Opportunities and Challenges Vandana Sharma, Principal Nutrition Scientist, Pharmavite	16:30 - 17:00
Closing Remarks from the Chairperson Julius Goepp, CEO, Evimero	17:00 - 17:00
Drinks Reception & Networking .....End of Day 1.....	17:00 - 17:00

Registration	08:15 - 09:00
Welcome note from MarketsandMarkets	09:00 - 09:05
CULTIVATING WELLNESS: PIONEERING THE FUTURE OF MICROBIOME AND PROBIOTICS
Opening Remarks from the Chairperson Julius Goepp, CEO, Evimero	09:05 - 09:10
Keynote Presentation: Functional Food & The Microbiome, Mitochondria Axis Christopher Damman, Associate Professor of Gastroenterology, University of Washington	09:10 - 09:45
Implementation of Metaproteomics approaches for characterizing the dynamic metabolic activities in human gut microbiomes. Robert Hettich, Distinguished Research Scientist \| Leader-Bioanalytical Mass Spectrometry Group of the Biosciences Division, Oak Ridge National Laboratory	09:45 - 10:20
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:20 - 11:05
Metabolic Characterization of Microbial Communities Peter Karp, Technical Director of the Bioinformatics Research Group, , SRI International	11:05 - 11:40
Developing microbiome-powered treatments for chronic skin conditions Lada Rasochova, CEO, Dermala	11:40 - 12:15
May the Fiber Be with You: Gut Microbiomes from a remote Amazon village to the undergraduate lab Kathrine Whiteson, Associate Professor, Irvine University of California, Irvine and co-Director, UCI Microbiome	12:15 - 12:45
Panel Discussion: Emerging Technologies in Microbiome & Probiotics Marina Santiago, Director of Strategic Projects, mbiomics Maya Ivanjesku, Chief Scientific Officer, M2B Pharma Larry Weiss, Chief Executive Officer and Founder, Symbiome	12:45 - 13:15
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:15 - 13:15
END OF CONFERENCE	13:15 - 13:15

CONFERENCE SPEAKERS

ADVISORS

Marina Santiago

Director of Strategic Projects, mbiomics

Ming Lei

President and CEO, Universal Sequencing Technology

Skyler Stein

President, Gladskin

SPEAKERS

Larry Weiss

Chief Executive Officer and Founder, Symbiome

Bruce Seal

Instructor, Biology, Oregon State University

Robert Schiestl

Director and Manager, Microbio Pharma

Tariq Warsi

Vice President, Novome Biotechnologies

TBA Senior Representative, Helaina

TBA Senior Representative, Helaina,

Christopher Damman

Associate Professor of Gastroenterology, University of Washington

Kevin Roelofs

Principal Consultant, Greenbeard Consulting LLC

Antonio Gomes

Principal Scientist, Xbiome

Zachery Lewis

Principal Consultant, Lewpine Consulting

Julius Goepp

CEO, Evimero

Kathrine Whiteson

Associate Professor, Irvine University of California, Irvine and co-Director, UCI Microbiome

Skyler Stein

President, Gladskin

Sahil Khanna

Professor of Medicine, Chair GI Hospital Practice, Associate Program Director Internal Medicine Residency Program, Medical Director Desk and Secretarial Operations, Mayo Clinic